ONTRUZANT

Google image searchProduct monograph

Active ingredient

trastuzumab, 150 MG/VIAL

DIN: 02524317

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE-USE VIAL

Schedule: Prescription / Schedule D

Company: SAMSUNG BIOEPIS CO., LTD

Date: 20-JUL-2022

ATC:

Reference brand drug: Herceptin

Search on Google